Bristol-Myers Squibb
BMY
#197
Rank
HK$907.63 B
Marketcap
HK$444.47
Share price
0.67%
Change (1 day)
30.76%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): HK$27.82

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is HK$27.87. In 2025 the company made an earnings per share (EPS) of HK$27.09 an increase over its 2024 EPS that were of -HK$34.61.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$27.822.7%
2025HK$27.09-178.28%
2024-HK$34.61-213.92%
2023HK$30.3830.2%
2022HK$23.33-6.04%
2021HK$24.83-179.29%
2020-HK$31.32-281.37%
2019HK$17.27-27.21%
2018HK$23.72
2016HK$20.90175.26%
2015HK$7.59-19.83%
2014HK$9.47-22.44%
2013HK$12.2134.48%
2012HK$9.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.40 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$54.96 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.26-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$16.10-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$220.98 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.37 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$20.04-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$73.20 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$27.85-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$54.41 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK